Back to 
Cubist Systematic Strategies, LLC
Cubist Systematic Strategies, LLC
IOVA
Showing 0 of 22 quarters
Position history for Cubist Systematic Strategies, LLC's holdings in Iovance Biotherapeutics, Inc.
No. Cubist Systematic Strategies exited its IOVA (Iovance Biotherapeutics) position in Q1 2024. Its Q4 2023 13F listed 468,821 shares worth $3.8M. Cubist Systematic Strategies already held IOVA in its Q4 2018 13F, the earliest on record, and held it in 19 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.